
According to ANTARA's report on August 13, the chairman of the Indonesian Retail Association, Budiharjo Iduansjah, is scheduled to meet with Minister of Health Budi Gunadi Sadikin to provide recommendations in the trade sector.
Budi Hartono stated on Tuesday (13th) in Jakarta,
We have been informed that we will be meeting with the Minister of Health this week.
The chairman stated that the meeting discussed not only the implementation regulations in the Government Regulation No. 28 of 2024 (PP) related to the 17th Health Law of 2023, particularly concerning the sale of tobacco products, but also will address the sales of drug products with the green circle logo, which are medicines that can be sold without a prescription.
Previously, the association had requested the government to reexamine government regulation number 28, especially the parts related to the sale of tobacco products. Budiharjo stated that they consistently support the government's decisions, but the clause in this regulation prohibiting the sale of cigarettes within 200 meters of educational centers and children's play areas needs to be discussed.
During a press conference in Jakarta regarding Government Regulation No. 28 of 2024, Budiharjo mentioned, "There are children's playgrounds in shopping centers, and retailers and some restaurants often sell cigarettes.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.